Humanized Mouse Models
We specialize in Humanized Mouse Models, overcoming species limits for in vivo human-specific disease studies. We construct diverse systems, including Immune Checkpoint knock-in and PBL/SRC SCID mice, by engrafting functional human cells to power crucial research in oncology, infectious diseases, and immunity.
The main purpose of Humanized Mouse Models is to create mouse models with human-specific biological components (such as human genes, cells, or tissues), enabling more accurate preclinical research that mimics human physiological or pathological conditions. Key features include precise integration of human-derived elements, high reproducibility of human-relevant phenotypes, and compatibility with diverse research scenarios.
Service Application Symbols
- Human immune system reconstitution models
- Human gene knock-in mouse models for target validation
- Humanized models for infectious disease research
- Efficacy testing of human-specific therapeutics
Next-generation CAR-T design: Overcoming TME barriers with armored payloads and logic-gated precision
CAR-T therapy has already had an impact in outcome expectations in B-cell malignancies, demonstrating how engineered immune cells can leverage antigen accessibility, trafficking, and effector function for dramatic clinical benefit. In solid tumors, however, the same rules do not apply. The tumor microenvironment acts less as a passive target and more like an active defense system, characterized by stiffened extracellular matrix, aberrant vasculature, hypoxia-driven metabolic collapse, and layered immunosuppressive signaling. As a result, CAR-T programs that show strong cytotoxicity in vitro often experience attenuated trafficking, accelerated exhaustion, and functional shutdown in vivo.
In this white paper, Creative Biolabs examines how in 2025-2026 the design philosophy has changed, moving the field towards system-level CAR design. ‘Armored CAR’ concepts are now recognized as essential strategies for bridging the gap between elegant constructs and reproducible antitumor activity in complex models. Creative Biolabs highlights key R&D hotspots in engineered cell therapy, including armored CARs, logic-gated targeting, checkpoint-evasive circuits, and TME-adaptive metabolism.
Creative Biolabs launches integrated preclinical platform to accelerate biotherapeutics development and de-risk IND submission
Integrated pre-clinical platform to accelerate therapeutic development







